Clinical manifestations and outcome of pseudomembranous colitis in an elderly population in Israel

Israel Medical Association Journal

Volumn 6, Issue 4, 2004, Pages 201-204

  Moshkowitz, Menachem ^a,b   Baruch, Efrat Ben ^b   Kline, Zeev ^c   Gelber, Moshe ^a,c   Shimoni, Zvi ^c   Konikoff, Fred ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c LANIADO HOSPITAL   (Israel)

Author keywords

Clostridium difficile; Elderly; Pseudomembranous colitis

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTACID AGENT; ANTIBIOTIC AGENT; AZTREONAM; CEPHALOSPORIN; CLINDAMYCIN; IMIPENEM; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UREIDOPENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ANEMIA; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BIOCHEMISTRY; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COLONOSCOPY; DEMOGRAPHY; DIARRHEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH CARE COST; HEMATOLOGICAL PARAMETERS; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; INSTITUTIONALIZATION; ISRAEL; LABORATORY TEST; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; NOSE FEEDING; NURSING HOME; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; PSEUDOMEMBRANOUS COLITIS; RECURRENCE RISK; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; SYMPTOMATOLOGY; URINARY TRACT INFECTION; ARTICLE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 2342457672     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
2. Mulligan ME, Citron D, Gabay E, Kirby BD, George WL, Finegold SM. Alternations in human fecal flora., including growth of Clostridium difficile, related to cefoxitin therapy. Antimicrob Agents Chemother 1984;26:343-6.
3. Reinke CM, Messick CR. Update in Clostridium difficile-induced colitis. Part 1. Am J Hosp Pharm 1994;51:1771-81.
4. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Eng J Med 1994;330:257-62.
5. Cleary RK. Clostridium difficile-associated diarrhea and colitis: clinical manifestation, diagnosis, and treatment. Dis Colon Rectum 1998;4(11): 1435-49.
6. Morris A, Jobe B, Stoney M, Deveney C, Deveney K. Clostridium difficile colitis: an increasingly agrressive iatrogenic disease. Dis Colon Rectum 20001;44:A5-26.
7. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995;169(5):480-3.
8. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995;38(4):350-4.
9. Gerding DN, Brazier JS. Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis 1993;16(Supp 4):S439-42.
10. Anand A, Bashey B, Mir T, Glatt AE. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 1994;89(4):519-23.
11. Buchner AM, Sonnenberg A. Epidemiology of Clostridium difficile infection in a large population of hospitalized US military veterans. Dig Dis Sci 2002;47(1):201-7.
12. Simor AE, Yake SL, Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term-care facility. Clin Infect Dis 1993;17(4): 672-8.
13. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalizes patients. J Infect Dis 1990;162(3):678-84.
14. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998;40(1):1-15.
15. Marts BC, Longo WE, Vernava AM 3rd, Kennedy DJ, Daniel GL, Jones I. Patterns and prognosis of Clostridium difficile colitis. Dis Colon Rectum 1994;37(8):837-45.
16. Benjaminov F, Zissin R, Novis B. Pseudomembranous colitis: clinical, endoscopic and radiological correlation - a 2-year experience. Harefuah 2001;140(3):197-200 (Hebrew).
17. Mylonakis E, Ryan ET, Calderwood, Clostridium difficile-associated diarrhea: a review. Arch Intern Med 2000;26:161(4):525-33.
18. Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990;11(60:283-90.
19. Cooper GS, Lederman MM, Salata RA. A predictive model to identify Clostridium difficile in hospitalized patients with diarrhea. Am J Gastroenterol 1996;91(1):80-4.
20. Bulusu M, Narayan S, Shetler K, Triadalfilopoulos G. Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol 2000;95(11): 3137-41.
21. Dharmarajan T, Sipalay M, Shyamsundar R, Norkus E, Pitchumoni C. Co-morbidity, not age predicts adverse outcome on clostridium difficile colitis. World J Gastroenterol 2000;6(2):198-201.
22. Watanakunakorn PW, Watanakunakorn C, Hazy J. Risk factors associated with Clostridium difficile diarrhea in hospitalized adult patients: a case-control study - sucralfate ingestion is not a negative risk factor. Infect Control Hosp Epidemiol 1996;17(4):232-5.
23. Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving ube feeding. Ann Intern Med 1998 15;129(12):1012-19.
24. Narzilai A, Eitan A, Erlich N, Toledano C. Increasing incidence of pseudomembranous colitis and its association with antibiotic therapy, Harefuah 1985;108(10):480-3 (Hebrew).
25. Tal S, Gurevich A, Guller V, Gurevich I, Berger D. Levi S. Risk factors for recurrence of Clostridium difficile-associated diarrhea in the elderly. Scand J Infect Dis 2002;34(8):594-7.